Protein Microarray Biosensors Based on Imaging Ellipsometry Techniques and Their Applications by 牛宇 et al.
REVIEW
Protein microarray biosensors based on
imaging ellipsometry techniques and their
applications
Yu Niu1,2, Gang Jin1✉
1 NML, Institute of Mechanics, Chinese Academy of Sciences, Beijing 100190, China
2 Graduate School of the Chinese Academy of Sciences, Beijing 100049, China
✉ Correspondence: gajin@imech.ac.cn
Received March 24, 2011 Accepted May 12, 2011
ABSTRACT
After years of development, biosensors based on
imaging ellipsometry and biosensors based on total
internal reﬂection imaging ellipsometry have been suc-
cessfully implemented in various engineering systems.
Their experimental setups, detection principles, and
biological and clinical applications are brieﬂy reviewed.
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INTRODUCTION
After the completion of the Human Genome Project,
proteomics entered the spotlight of biological research.
Proteomics has increasingly drawn attention from simply
identifying novel genes to determining the functions of the
proteins that they encode. Similar to genome research,
studying the characteristics of protein-protein interactions
requires the ability to perform massively parallel analyses (Yu
et al., 2006). Microarray technology is a promising method to
provide an effective solution for simultaneous detection of
various analytes in a single experiment (Bally et al., 2006).
Microarrays are built by assembling a set of ligands onto a
solid surface and are suitable for high-throughput analyses.
Compared to traditional immunological methods, protein
microarrays have several distinct advantages (Rich and
Myszka, 2007; Klenkar and Liedberg, 2008), including low
consumption of both the ligand and analyte, parallel
screening of multiple interactions, and rapid response read-
out. Based on diverse detection technologies, protein micro-
arrays can form the basis of various types of biosensors as
the ideal analytical tools for proteomics (Templin et al., 2003).
Biosensors fall into two categories: labeled and label-free
biosensors. Commonly used labels include ﬂuorescent dyes
(Ligler et al., 2003), enzymes (Engvall and Perlmann, 1971),
radioactive labels (Aicher et al., 2003), and the more recently
developed quantum dot (Chan and Nie, 1998). They provide
ultra-high throughput readout of protein-protein interactions
with good detection sensitivity, speciﬁcity, and reliability. Many
of the commercially available protein microarray biosensors
are labeled (Bally et al., 2006; Boozer et al., 2006). However,
such arrays have several drawbacks (Kodadek, 2001). First,
labeling may change protein conformations and impair
bioactivity. This can be especially severe for low molecular
weight proteins and peptides with only a few epitopes.
Second, labeling may result in difﬁculties in quantiﬁcation.
In addition, the labeling process is normally time and labor
intensive. To solve these problems, substantial effort has
been devoted to the development of label-free protein
biosensors, though their detection sensitivity for certain
biomolecules is lower than that of labeled biosensors
(Anastasiadou et al., 2008).
Detection of interactions with label-free biosensors relies
on acoustic methods, notably surface plasmon resonance
(SPR) (Hutter and Fendler, 2004), imaging ellipsometry (Jin
et al., 1995), revamping calorimetry (Ladbury and Chowdhry,
1996), quartz crystal resonators (Lucklum and Hauptmann,
2000), nanowires (Wanekaya et al., 2006), and ion channel
switch technology (Cornell et al., 1997). Currently, SPR
biosensors play a dominant role because they have been
intensively developed for commercial applications in the last
10 years.
SPR is a label-free detection method for analyzing
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biomolecular interactions in real-time (Jain et al., 2007). By
replacing photonic detectors with CCD cameras, SPR
imaging (SPRi) improves the throughput of conventional
SPR to analyze multiple interactions in parallel. SPRi offers
the possibility to simultaneously monitor hundreds of biologi-
cal interactions and estimate the kinetic parameters of the
interactions between the ligands immobilized on the biosen-
sor surface and analytes in solution (Scarano et al., 2010;
Kodoyianni, 2011). Thus far, SPRi has been used for a wide
range of biological applications (Campbell and Kim, 2007),
varying from hybridization reactions with DNA to protein–pro-
tein interactions. However, to date, little has been done to
apply SPRi in commercial practices, such as clinical
diagnostics, food analysis, and pharmaceutical research
(Kodoyianni, 2011).
Ellipsometry is a conventional optical technique for
measuring changes in light polarization states, and it can
determine ﬁlm thickness with a resolution of ≤ 0.01 nm as a
nondestructive and label-free method (Arwin, 1998). Imaging
ellipsometry is an enhancement of standard single beam
ellipsometry that combines the power of ellipsometry with
microscopy (Jin, 2008). A high spatial resolution, on the order
of micrometers (laterally) and sub-nanometers (vertically),
can be achieved with a large viewable area (several square
centimeters), which allows simultaneous multi-sensing of
target microarrays.
The concept of biosensors based on imaging ellipsometry
(BIEs) was proposed in 1995 for the visualization of
biomolecular interactions (Jin et al., 1995, 1996). Over the
past 16 years, commercial products based on single
wavelength and spectroscopic imaging ellipsometry, made
by the Nanoﬁlm Company (http://www.nanoﬁlm.de/; Gedig
et al., 2008), have entered the market, and many signiﬁcant
improvements (e.g., the off-null sampling method (Chen et al.,
2007a), spectroscopic technique (Meng and Jin, 2011),
automatic control, microarray surface modiﬁcation (Wang
and Jin, 2003a, 2004a, b), micro-ﬂuidic reactors (Jin and
Wang, 2002; Wang et al., 2006), bio-system optimization, and
protein interaction databases) have been introduced into BIE
to improve its performance and feasibility. Therefore, BIE has
been developed into an automatic device for quantitative and
high-throughput protein analysis (Jin et al., 2011). BIE’s
sensitivity is on the order of 1 ng/mL for immunoglobulin G
detection without any labeling (Jin, 2008; Qi et al., 2009b).
Thus far, BIE has successfully been used in a wide range of
biomedical and clinical detection applications (Qi et al.,
2009a, 2009b, 2010; Huang et al., 2011).
In recent years, biosensors based on total internal
reﬂection imaging ellipsometry (BTIRIEs) (Chen et al.,
2007b) have been developed to meet the need of kinetic
process analysis of biomolecular interactions. In BTIRIE
systems, imaging ellipsometry is performed in the total
internal reﬂection mode, and the change of the evanescent
wave ﬁeld near the sensing surface is used to describe the
biomolecular interactions. BTIRIE offers a much higher
sensitivity because of its phase-sensitive property (Liu
et al., 2011). Theoretically, BTIRIEs are 30 times more
sensitive than the conventional SPR method (Asinovski et al.,
2008) after optimization, including polarization setting, the
spectroscopic technique, and the use of a cooled imaging
device to improve the signal-noise ratio and detection limit
(Liu et al., 2010, 2011).
In this review, the working principles, experimental
approaches, and biomedical applications of two types of
biosensors based on imaging ellipsometry are summarized.
BIEs
Generally, a BIE system can be divided into four parts: the
microarray reactor, the imaging ellipsometer, the control
system, and the biosensor database, as shown in Fig. 1
(Jin, 2008). The microarray reactor serves to fabricate the
protein microarray and accommodate biomolecular interac-
tions. Using the micro-ﬂuidic reactor, various ligands are
delivered to different cells to form a sensing array, and each
sensing surface can be prepared homogeneously under the
ﬂow condition. The imaging ellipsometer acts as a reader for
data acquisition from the microarray. Imaging ellipsometry is
an enhancement of standard ellipsometry, which combines
the power of ellipsometry with microscopy (Jin et al., 1995,
1996). The latest imaging ellipsometer is a spectroscopic
imaging ellipsometry (SIE) system (Meng and Jin, 2011).
Compared to single-beam imaging ellipsometers, SIEs have
advantages in achieving the thickness distribution on a solid
substrate with optical lateral resolution on the order of microns
upon magniﬁcation (Meng and Jin, 2011). SIEs can be used
to visualize ultra-thin ﬁlms and the concentration change of a
molecular mass surface (Jin et al., 1995, 1996). Slight
variations of thickness can be remarkably distinguished by
imaging ellipsometry, and the results are represented as
grayscale images (Jin, 2008). The grayscale value is
approximately linearly proportional to the thickness of the
molecular ﬁlm (Chen et al., 2007a). The control system is
responsible for combining the microarray reactor with the
imaging ellipsometer and functions to control the hardware’s
mechanical motion and obtain results in images. Indeed, the
control system is the central piece of an automated biosensor.
The biosensor database is used to aid BIE users in
determining optimized experimental conditions by comparing
previously stored data to current requirements.
BIE DETECTION PRINCIPLE AND PROCEDURES
BIEs are used to visualize the thickness distribution of protein
layers attached to a patterned surface on a solid substrate, as
shown in Fig. 2 (Jin, 2008). A ligand and its receptor (e.g., an
antibody and its corresponding antigen, respectively) can
assemble into bio-complexes due to their afﬁnity. The optical
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biosensor is based on the fact that each reactant, such as a
ligand, is immobilized to a surface to form a monolayer, acting
as a bioprobe via its bioactivity. The other reactant, such as
the analyte (or receptor), exists in a solution. The bioprobe is
then exposed to the solution containing the analyte. When the
analyte in the solution interacts with its corresponding ligand,
they assemble into a complex based upon their inherent
binding afﬁnity. The molecular mass surface concentration
where the interaction takes place becomes higher than before
exposure to the analyte solution. A signiﬁcant increase of the
surface concentration indicates that the solution contains the
receptor bound to the ligand. With the visualization of imaging
ellipsometry, which has high vertical and lateral spatial
resolution (on the order of 0.1 nm and 1 μm, respectively),
the increase in surface concentration can be determined, and
in this way, the existence of the analyte in the solution is
veriﬁed. Many bioprobes can be arranged in a matrix to form a
protein microarray for multi-detection (Jin and Wang, 2002;
Wang and Jin, 2003b).
The general detection procedure with BIEs can be
summarized with the following successive steps. First, the
substrate is modiﬁed with chemical reagents to attach to a
chemically modiﬁed surface. Then, the modiﬁed surface is
placed in the micro-ﬂuidic reactor system to form patterned
cells in an array format. Different ligand solutions are
separately pumped into each cell to immobilize ligand on
the microarray. Following this, the analyte solution is
delivered to react with the ligands. Finally, the microarray is
sampled by the imaging ellipsometry reader to determine
molecular interaction results.
BIE BIOMEDICAL AND CLINICAL APPLICATIONS
BIEs are usually set to work in the ex-situ mode, which is
suitable for most clinical detection applications (Jin et al.,
2011). Thus far, BIEs have successfully been used in a wide
range of biomedical and clinical detection applications. Here,
some typical applications are presented.
Antibody screening
Antibody screening is an important process in a wide range of
biomedical and clinical applications. Niu et al. (2011)
employed a BIE as an antibody screening platform to
compare and evaluate ﬁve ricin antibodies (named 7G7,
pVHHS1, 5S1R, VHHS1, and S1R). Ricin, whose estimated
oral lethal dose is < 20mg/kg body weight in humans, is one
of the most potent plant toxins known. Antibodies against ricin
can identify and neutralize the toxin quickly and efﬁciently and
are thus of great signiﬁcance for the diagnosis and treatment
of patients exposed to ricin poison. All ﬁve antibodies react
with 50 μg/mL ricin but not abrin, a ricin analog (Fig. 3A).
When the ricin concentration was decreased to 1 ng/mL, the
limit of detection (LOD) values of 7G7, pVHHS1, 5S1R,
Figure 1. Schematic diagram of BIE. The solid arrow
indicates the physical ﬂow of a sample; the empty arrows
indicate the data ﬂow (Jin, 2008).
Figure 2. BIE detection principle. The incident wave of the
polarized light as probe beam irradiates the sample and the
reﬂective beam carries sample information, such as surface
concentration of the immobilized protein molecules. The three
parts of the sample, including bear substrate, ligand layer and
complex layer, can be differentiated in the ellipsometric image
that reveals different reﬂection intensities in grayscale. Surface
concentration distribution of the protein layer can be further
demonstrated in a 3D plot (Jin, 2008).
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VHHS1, and S1R are 5 ng/mL, 500 ng/mL, 1 ng/mL, 1 μg/mL,
and 10 ng/mL, respectively (Fig. 3B), which essentially
agrees with enzyme-linked immunosorbent assay (ELISA)
results. Having the lowest LOD value, 5S1R is considered the
best ricin antibody, which may play potential roles in clinical
diagnosis and therapy.
Detection of disease biomarkers
Biomarker detection is a powerful method to examine the
status of patient tissue and to predict clinical outcomes. BIEs
have been applied in this ﬁeld and demonstrated some
success.
Niu et al. (2008) developed a BIE protocol for quantitative
measurement of CD146 for tumor marker detection. The
CD146 glycoprotein, which may be involved in tumor
angiogenesis in endothelial cells, was originally identiﬁed as
a tumor marker for melanoma. First, CD146 antibody was
immobilized by absorption to a protein G-modiﬁed silicon
substrate. Then, a calibration curve was established for
quantitative CD146 detection, and the relationship between
the BIE signal y (grayscale value) and the CD146 concentra-
tion x (ng/mL) was established (y = 3.3ln(x) + 91.3, as shown
in Fig. 4). Finally, 18 serum samples were analyzed to
quantify their CD146 concentrations, with detection sensitivity
on the order of ng/mL. The majority of these results
signiﬁcantly statistically agree with those of ELISA measure-
ments (Fig. 4C).
Qi et al. (2009b) analyzed 169 patient serum samples by
BIE for clinical diagnosis of hepatitis B virus (HBV) infection.
Five markers of HBV, including hepatitis B surface antigen
(HBsAg), hepatitis B surface antibody (HBsAb), hepatitis B e
antigen (HBeAg), hepatitis B e antibody (HBeAb), and
hepatitis B core antibody (HBcAb), are generally used as
clinical markers to detect HBV infection. BIE simultaneously
detects ﬁve markers in eight samples in the same microarray
in only 1 h, whereas ELISA can only detect one marker on
each plate over a longer time (ligand immobilization and
assaying lasts 1–2 days). Moreover, the BIE results are in
good agreement with the ELISA results. Sensitivities of
1 ng/mL and 1 IU/mL for HBsAg and HBsAb detection,
respectively, have been achieved. The cutoffs (CoVs, i.e.,
the percentage over the values of the corresponding to
negative control produced by national reference negative
samples) derived from the receiver operating characteristic
(ROC) curves of the ﬁve markers (HBsAg, HBsAb, HBeAg,
HBeAb, and HBcAb) were deduced to be 15%, 18%, 15%,
20%, and 15%, respectively.
Anastasiadou et al. (2008) evaluated the potential of
polarimetric imaging for the early detection and therapy of
cervical cancer. The current strategy for cervical cancer
detection and therapy is based on detailed examination via a
colposcopy. Although being well established, a colposcopy is
a very difﬁcult and operator-dependent method, which may
lead to a signiﬁcant proportion of false diagnoses. To develop
an additional clinical method, the authors performed the
simple linear degree of polarization technique on cone biopsy
specimens and found some preliminary but quite encouraging
results. A clinical trial of this device is ongoing to compare this
imaging modality with classical colposcopy for visualizing
cervical precancerous or cancerous lesions.
Jin et al. designed a tumor marker spectrum composed of
alpha-fetoprotein (AFP), alpha-L-fucosidase (AFU), and
ferritin as a trial to explore its feasibility for the clinical
detection of liver cancer, the most prevalent cancer in China,
to increase diagnostic speciﬁcity (Jin et al., 2011). AFP and
Figure 3. Ricin detection with BIE. (A) 3D image of the interaction between ricin and its ﬁve antibodies: Columns “a”, “b”, “c”, “d”,
and “e” are corresponding to results of 7G7, pVHHS1, 5S1R, VHHS1, and S1R, respectively (Niu et al., 2011). All of the ﬁve ricin
antibodies were immobilized and reacted with blocking buffer (row 1), ricin (row 2) or abrin (row 3). (B) LOD values for ﬁve ricin
antibodies (Niu et al., 2011).
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AFU are considered novel markers for liver cancer, while
ferritin is a marker of many types of cancer. Quantitative
detection of AFP, AFU and ferritin are achieved by calibration
against standards. The calibration curves of AFP, AFU and
ferritin are y = 13.4 lg(x) + 79.7 (detection range from 1 to
64 ng/mL), y = 24.6 lg(x) + 88.1 (detection range from 1 to
64 U/L), and y = 14.5 lg(x) + 76.8 (detection range from 5 to
160 ng/mL), respectively. Here, y is the BIE signal (in
grayscale value) and x is the marker concentration (in
ng/mL or U/L). The concentrations of AFP, AFU, and ferritin in
56 serum samples composed of 32 normal and 24 liver
cancer patients were measured (shown in Fig. 5A), and the
results were compared to those obtained by routine clinical
approaches, such as enhanced chemiluminescence immu-
noassay (ECLIA) for AFP, ELISA for AFU, and immunoturbi-
dimetry for ferritin. The Pearson’s correlation coefﬁcients of
the comparisons are 0.532, 0.948, and 0.937 for AFP, AFU,
and ferritin, respectively, which indicates that the results
obtained by BIE and routine approaches are signiﬁcantly
statistically similar. ROC curves for single marker detection
and logistic regression for joint marker tests were introduced
to evaluate BIE’s performance in the diagnosis of liver cancer.
The area under the curve (AUC), which provides the
relationship between the sensitivity and speciﬁcity for an
independent test, is 0.827, 0.782, and 0.380 for AFP, AFU,
and ferritin, respectively (shown in Fig. 5B). However, the
AUC increases to 0.884 for joint detection of AFP and AFU,
while ferritin is much less related to these two markers. This
indicates that the joint detection of tumor markers AFP and
AFU may be more useful than their individual detection for
clinical liver cancer diagnosis.
Detection of bacterial pathogens
Bacteria are one of the greatest dangers to human health and
can cause a series of diseases. Bae et al. (2004) developed
an immunosensor with imaging ellipsometry for the purpose
of monitoring bacterial pathogens (Bae et al., 2004; Choi and
Oh, 2008). Yersinia enterocolitica was selected as a typical
bacterial pathogen in their study. To fabricate the immuno-
sensor, protein G spots were placed on a gold surface
modiﬁed by 11-mercaptoundecanoic acid (11-MUA), and then
monoclonal antibody was adsorbed onto the protein G spots.
The ellipsometric image of the protein G spot and the
antibody-adsorbed protein G spot are then obtained. The
change in the mean optical intensity of the protein G spot to
the various concentrations of Y. enterocolitica is shown in
Fig. 6. The immunosensor using imaging ellipsometry suc-
cessfully detected Y. enterocolitica at concentrations ranging
from 103 to 107 cfu/mL.
Detection of viruses
Phage M13KO7 is a virus that infects Escherichia coli.
Because its size and structure is similar to viruses that infect
humans, phage M13KO7 is used as a model to develop BIE
for direct viral detection. Qi et al. (2009a) directly detected
different phage M13KO7 samples, such as natural and
puriﬁed samples and different batches of samples with
various concentrations, with BIE. Their results in Fig. 7A
demonstrate that phage M13KO7 can be speciﬁcally cap-
tured by the ligand when an M13KO7 solution passes over
the surface, resulting in a signiﬁcant increase in the thickness
Figure 4. CD146 detection with BIE. (A) CD146 detection: Protein G was immobilized in all of the 8 units. BSA reacts in rows “a”
and “b”, while CD146 antibody reacts in rows “c” and “d”. After blocked by the blocking buffer, one concentration of the CD146
standard sample was added to rows “b” and “d”, while PBSTwas added to rows “a” and “c”. In that case, rows “a” and “b” were blank
controls, whereas row “c” was negative control (Niu et al., 2008). (B) Calibration curve for quantitative CD146 detection (Niu et al.,
2008). (C) Comparison between BIE and ELISA detection results of CD146 from sera of 18 patients: The BIE and ELISA detection
results are plotted. A Pearson correlation coefﬁcient of 0.923 indicates that the results of the two methods are signiﬁcantly correlated
at the level of 0.05 (Niu et al., 2008).
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of the anti-M13KO7 binding layer. The detection limit for
phage M13KO7 is 109 pfu/mL. AFM was also used to conﬁrm
that phage M13KO7 was directly captured by ligands on the
surface (Fig. 7B). This indicates that BIE is competent for
direct detection of phage M13KO7 and has potential in the
ﬁeld of human virus detection.
Avian inﬂuenza virus (AIV) has caused global concern as a
potential pandemic threat to human life. Qi et al. (2010) used
BIE for rapid AIV detection. A sensing surface with multiple
antibodies against AIV in a patterned array was constructed
as a probe to capture AIV by speciﬁc afﬁnity between the
antibodies and virus (Fig. 8A). The H5N1 AIV subtype (highly
pathogenic) was detected with a sensitivity of 2.56×10−3
TCID/mL, which was conﬁrmed by scanning near-ﬁeld optical
microscopy performed in a shear force mode (the image of
AIV captured on the sensing surface is shown in Fig. 8B).
BTIRIE EXPERIMENTAL SETUP AND DETECTION
PRINCIPLE
In a BTIRIE system, the internal reﬂection illumination is
realized by a coupling prism contacting the glass slide of a
micro-ﬂuidic reactor array (Chen et al., 2007b). The other side
of the slide is coated with a thin gold ﬁlm as a substrate for
Figure 5. BIE detection of tumor markers AFP, AFU, and ferritin. (A) Joint detection of AFP, AFU, and ferritin: Columns “a”, “b”,
and “c”were immobilized with anti-AFP, anti-AFU, and anti-ferritin as ligands, respectively. Rows “1”, “2”, “3”, “4”, and “5”were reacted
with 2 normal sera, 2 patient sera and negative control, respectively (Jin et al., 2011). (B) ROC curve analysis (Jin et al., 2011).
Figure 6. Ellipsometric images (BIE) of protein G spots bound with various concentrations of Y. enterocolitica. (A) 0 cfu/mL,
(B) 105 cfu/mL, and (C) 107 cfu/mL (Bae et al., 2004).
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ligand immobilization. The probe beam passes through a
polarizer and compensator perpendicularly into the window of
glass prism and ﬁnally onto the gold ﬁlm (Fig. 9).The incident
angle of BTIRIE is ﬁxed and is larger than the critical angle of
total internal reﬂection so that the evanescent wave appear-
ing between the interface of the substrate and the tested
solution is used to speciﬁcally illuminate the biomolecular
interaction in the micro-ﬂuidic reactor array (Chen et al.,
2007b). While the evanescent wave ﬁeld passes the
biomolecular layers on the interaction surface, the polariza-
tion state of the reﬂection is modiﬁed. Thus, BTIRIE is
used to automatically detect label-free protein interactions
Figure 7. BIE detection of phage M13KO7. (A) A grayscale image veriﬁes speciﬁc interaction between bio-GP3 and phage
M13KO7: Avidin was ﬁrst immobilized on all areas, followed by immobilization of bio-GP3 onto areas “a2”, “a3”, “a4”, “b2”, “b3”, and
“b4”. PBST was added to areas “a2” and “b2” as control; areas “a3”, “b3” and “a4”, “b4” were used to detect phage M13KO7 and
negative sample (SARS), respectively (Qi et al., 2009a). (B) An AFM image taken from 2.5 μm scanning distance on top of the phage
detection area: The overall conﬁguration of phage M13KO7 on the mica surface is presented. The round particles in the image are
contaminants in the culture solution, while the phageM13KO7 shows as a long ﬁlament with a length of ~ 1 μm, a height of ~ 4 nm and
a width of ~ 40 nm (Qi et al., 2009a).
Figure 8. BIE detection of AIV samples. (A) A grayscale image of AIV detection: Antibody ScFv was bound on columns “a” and
“b”; antibody 4A4 in ascites was bound on columns “c” and “d”. H5N1 was detected in row “1”; H9N2 was detected in row “2”; and row
“3” was used as a ligand control (Qi et al., 2010). (B) An image of SNOM in a shear force mode for H5N1 detection (Qi et al., 2010).
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in real-time. The information of these biomolecular layers are
deduced by analysis of the polarized state of the reﬂection.
Further, the shallow illumination depth of the evanescent
wave ﬁeld makes measurements less disturbed by refractive
index mismatch, non-uniformity, and ﬂow in the test solution.
BTIRIE APPLICATIONS
In situ BTIRIE is a powerful tool for detecting interactions
between biomolecules having weak afﬁnity, with high
sensitivity in real-time. A comparison of the real-time
detection sensitivity of CD146 was made between the BIE
and BTIRIE techniques.
Under the same experimental condition in the BIE
measurements (Niu et al., 2008), Liu et al. (2009) applied
BTIRIE to quantitatively detect various concentrations
(0.1–100 ng/mL) of CD146 (Fig. 10). Although at the lowest
concentration of 0.1 ng/mL, the BTIRIE signal is still
signiﬁcantly higher than the reference. This implies that the
detection sensitivity of BTIRIE reaches the order of
0.1 ng/mL, which is > 10 times more sensitive than BIE.
Mustafa et al. (2010) exploited spectroscopic BTIRE as a
highly sensitive method to detect β-amyloid peptide (Aβ-16).
Monoclonal DE2 antibodies were electrostatically immobi-
lized on a gold surface to capture Aβ-16 over a wide range of
concentrations. The results demonstrate that interaction
between DE2 monoclonal antibodies and Aβ-16 was highly
Figure 9. Schematic diagram of the total internal reﬂec-
tion imaging ellipsometry biosensor (BTIRE). The light from
a Xe lamp was guided by an optical ﬁber and expanded by the
collimating system. After passing the polarizer and compen-
sator, the polarized collimated beam propagated perpendicu-
larly to the prism and onto the sensing surface. The gold
sensing surface was immobilized with ligand for biomolecule
interaction in the contacting micro-ﬂuidic reactor array. When
the incident angle was larger than the critical angle, the
evanescent wave appeared sharply at the sensing surface to
detect biomolecule interaction in very shallow depth from the
surface. The reﬂected light carrying surface information was
then imaged by CCD camera after passing the analyzer (Chen
et al., 2007b).
Figure 10. Real-time recording of the dynamic process of CD146 binding with its antibody at various concentrations.
Baseline reading was ﬁrst recorded (region 1), followed by NHS-EDC activation of carboxyl group assembling on the gold substrate
(region 2), PBS rising (region 3), CD146 antibody immobilization (region 4), PBS rinsing (region 5), blocking (region 6), PBS rinsing
(region 7), and CD146 binding (region 8). Curves “a”–“g” correspond to CD146 concentrations of 100, 40, 20, 10, 1, 0.1, and 0 ng/mL,
respectively (Liu et al., 2009).
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speciﬁc, with an afﬁnity constant KD = 1.46×10
−8 mol/L, and
the BTIRE detection sensitivity was as low as 0.05 ng/mL.
Vesicle absorption is used to study cell membrane
properties due to their similar lipid bilayer structures. Liu et al.
applied BTIRIE to visualize the non-speciﬁc absorption and
release process of vesicles (made of 1,2-Dioleoyl-sn-glycero-
3-phosphocholine) from a poly-L-lysine-modiﬁed gold surface
(Fig. 11; Jin et al., 2011). Region 6 of curves “a” and “b” in
Fig. 11 corresponds to the non-speciﬁc absorption of vesicles
onto the poly-L-lysine surface. In region 7, the glucose
solution was changed at a 5 μL/min ﬂux. The corresponding
signal decrease indicates vesicles being rinsed off by the
glucose solution. When the ﬂux increased to 10 μL/min
(region 8), the signal remained nearly the same because
the ﬂux was not large enough to remove more vesicles. By
increasing the ﬂux to 30 μL/min (region 9), the signal in curves
“a” and “b” further decreased but remained constant in
reference curve “c”. These results demonstrate that vesicles
were removed from the surface by the shear-force of the
glucose ﬂux, by destroying the non-speciﬁc adsorption
between vesicles and poly-L-lysine. By increasing the ﬂux
to 40 μL/min, the signal in curves “a”, “b”, and “c” decreased
simultaneously, indicating that the poly-L-lysine was also
removed from the surface. These results were veriﬁed in a
parallel experiment performed with a phase contrast micro-
scope (NIKON, TI-U, Japan), indicating that the process of
vesicle absorption, release, and poly-L-lysine layer destruc-
tion on the surface can be visualized by BTIRIE.
CONCLUSIONS AND PROSPECTIVE
Over the last 16 years, biosensors based on imaging
ellipsometry (BIEs and BTIREs) have been developed as
label-free, high-throughput, and automated techniques for
protein detection in a simple operation. The successful
experiments described above prove that these techniques
are suitable tools for biomedical and clinical applications.
Aside from having the same advantages of being label-free,
non-contact, and ultra-highly sensitive, BTIRIE excels over
BIE by avoiding errors in the ex situ mode. Having high
potential to monitor weak and transient biological interactions
in real-time, which is very difﬁcult for traditional approaches,
BTIRIE has become a powerful technique for biomolecular
detection as well as in clinical diagnosis.
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ABBREVIATIONS
AIV, avian inﬂuenza virus; BIEs, biosensors based on imaging
ellipsometry; BTIRIEs, biosensors based on total internal reﬂection
imaging ellipsometry; ECLIA, enhanced chemiluminescence immu-
Figure 11. Real-time recording of the dynamic process of vesicle absorption and release from the surface (Jin et al., 2011).
Recording of NHS-EDC activation of carboxyl group assembling on gold substrate (region 1), followed by pure water rising (region 2),
1:100 poly-L-lysine immobilization (region 3), pure water rinsing (region 4), pH 10 glucose solution rinsing (region 5), incubation of
vesicles in pH 10 glucose solution, binding to the poly-L-lysine surface (region 6), and ﬂux of pH 10 glucose solution at increasing ﬂow
rates (5, 10, 30, 40, and 45 μL/min in regions 7 to 11, respectively).
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noassay; HBV, hepatitis B virus; LOD, limit of detection; SIE,
spectroscopic imaging ellipsometry; SPR, surface plasmon reso-
nance; SPRi, SPR imaging
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